LabGenomics Co. Ltd (084650) — Cash Flow-to-Debt Ratio
LabGenomics Co. Ltd (084650) has a Cash Flow-to-Debt Ratio of -0.08x as of September 2025, meaning its operating cash flow of ₩-6.41 Billion could theoretically repay 0% of its total liabilities (₩76.00 Billion) in one year. See 084650 financial flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
LabGenomics Co. Ltd Cash Flow-to-Debt Ratio (2014–2024)
Historical debt coverage capacity for LabGenomics Co. Ltd across 11 annual periods. For the full cash flow conversion analysis, see how efficiently does LabGenomics Co. Ltd generate cash.
Annual Cash Flow-to-Debt Ratio for LabGenomics Co. Ltd (2014–2024)
Year-by-year debt coverage analysis for LabGenomics Co. Ltd. Check earnings quality score of LabGenomics Co. Ltd to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.16x | ₩-12.99 Billion | ₩79.35 Billion | ▼ -676.9% |
| 2023 | 0.03x | ₩2.42 Billion | ₩85.31 Billion | ▼ -98.3% |
| 2022 | 1.69x | ₩69.87 Billion | ₩41.32 Billion | ▲ +20.5% |
| 2021 | 1.40x | ₩65.36 Billion | ₩46.57 Billion | ▼ -15.8% |
| 2020 | 1.67x | ₩46.37 Billion | ₩27.82 Billion | ▲ +896.5% |
| 2019 | 0.17x | ₩3.19 Billion | ₩19.06 Billion | ▲ +367.4% |
| 2018 | 0.04x | ₩608.03 Million | ₩16.99 Billion | ▲ +159.3% |
| 2017 | -0.06x | ₩-1.06 Billion | ₩17.52 Billion | ▼ -143.1% |
| 2016 | 0.14x | ₩2.54 Billion | ₩18.17 Billion | ▼ -43.9% |
| 2015 | 0.25x | ₩2.38 Billion | ₩9.54 Billion | ▼ -21.9% |
| 2014 | 0.32x | ₩3.15 Billion | ₩9.86 Billion | — |